Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration

References

• Cancer Registry of Norway, 2000. www.kreftregisteret.no/forekomst_og_overlevelse_2000/testis/incidence.htm.
   Google Scholar
• Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87: 293–8
   PubMed Web of Science ®Google Scholar
• Peckham M. Testicular cancer. Acta Oncol 1988; 27: 439–53
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Huddart RA, Horwich A. Managing testicular cancer. BMJ 2001; 322: 1583–8
   PubMed Web of Science ®Google Scholar
• Aass N, Klepp O, Cavallin-Ståhl E, Wieklünd H, Unsgoard B, Baldetorp L, et al. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: A multicenter experience. J Clin Oncol 1991; 9: 818–26
   PubMed Web of Science ®Google Scholar
• Collette L, Sylvester RJ, Stenning SP, Fossa SD, Mead SM, de Wit R, et al. Impact of the treating institution on survival of patients with “poor-prognosis” metastatic nonseminoma. J Natl Cancer Inst 1999; 91: 839–46
   PubMedGoogle Scholar
• Begg CB, Carbone PP, Elson PJ, Zelen M. Participation of community hospitals in clinical trials. Analysis of five years experience in the Eastern Cooperative Oncology Group. New Engl J Med 1982; 306: 1076–80
   PubMed Web of Science ®Google Scholar
• Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352–62
   PubMed Web of Science ®Google Scholar
• Norum J, Nordøy T, Wist E. Testicular cancer treated in a minor general oncology department. Eur J Cancer 1995; 31A: 293–5
   PubMedGoogle Scholar
• Mostofi FK, Sobin LH. Histological typing of testis tumours. International Histological Classification of Tumours, No 16. World Health Organization, Geneva 1979; 1–39
   Google Scholar
• Peckham MJ, McElwain TJ, Barrett A, Hendry WF, et al. Combined management of malignant teratoma of the testis. Lancet 1979; 2: 267–70
   PubMed Web of Science ®Google Scholar
• International Germ Cell Consensus Classification. A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594–603
   PubMed Web of Science ®Google Scholar
• Klepp O, Dahl O, Flodgren P, Stierner U, Olsson AM, Olbring J. Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer. Eur J Cancer 1997; 33: 1038–44
   PubMed Web of Science ®Google Scholar
• Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Peto R, Pike MC, Armitage P, Braslow NE, Cox BR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Germà-Lluch JR, Garcia del Muro X, Maroto P, Paz-Ares L, Arranz JA, Guma J, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol 2002; 42: 553–62
   PubMedGoogle Scholar
• Rosenthal MA, Stuart-Harris RC, Tiver KW, Langlands AO, Kefford RF. Single institution experience with non-seminomatous germ cell tumours of the testis: local perspectives on a curable cancer. Aust NZ J Med 1991; 21: 857–62
   PubMedGoogle Scholar
• Gudbjartsson T, Magnusson K, Bergthorsson J, Barkardottir RB, Agnarsson BA, Thoroddsen B, et al. A population-based analysis of increased and improved survival of testicular cancer patients in Iceland. Scan J Urol Nephrol 2003; 37: 292–8
   PubMed Web of Science ®Google Scholar
• Toner GC, Neerhut GJ, Schwarz MA, Thursfield IJ, Sandeman TF, Giles GG, et al. The management of testicular cancer in Victoria, 1988–1993. Med J Aust 2001; 174: 328–31
   PubMedGoogle Scholar
• Steele GS, Richie JP, Stewart AK, Menck HR. The national cancer database report on patterns of care for testicular carcinoma, 1985–1996. Cancer 1999; 86: 2171–83
   PubMedGoogle Scholar
• Francis R, Bower M, Brunstrom G, Holden L, Newlands ES, Rustin GJ, et al. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 2000; 36: 1925–32
   PubMed Web of Science ®Google Scholar
• Howard GCW, Clarke K, Elia MH, Hotcheon AW, Kaye SB, Windsor PM, et al. A Scottish national audit of current patterns of management for patients with testicular non-semimatous germ-cell tumors. Br J Cancer 1995; 72: 1303–6
   PubMedGoogle Scholar
• Foster RS, Roth BJ. Clinical stage I nonseminoma: surgery versus surveillance. Semin Oncol 1998; 25: 145–53
   PubMed Web of Science ®Google Scholar
• Thornhill JA, Walsh A, Conroy RM, Fennelly JJ, Kelly DG, Fitzpatrick JM. Physician-dependent prognostic variables in the management of testicular cancer. Br J Urol 1988; 61: 244–9
   PubMedGoogle Scholar
• Oshima A, Kitagawa T, Ajiki W, Tsukuma H, Takenaka S, Iura A. Survival of testicular cancer patients in Osaka, Japan. Jpn J Clin Oncol 2001; 31: 438–43
   PubMedGoogle Scholar
• Feuer EJ, Sheinfeld J, Bosl GJ. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. J Natl Cancer Inst 1999; 91: 816–8
   PubMedGoogle Scholar
• Bagshawe KD, Begent RHJ, Newlands ES, Rustin GJS. What sort of oncology team should treat testicular teratoma?. Lancet 1985; I: 646
   Google Scholar
• Harding MJ, Paul J, Gillis CR, Kaye SB. Management of malignant teratoma: does referral to a specialist unit matter?. Lancet 1993; 341: 999–1002
   PubMedGoogle Scholar
• Bray F, Sankila R, Ferlay R, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38: 99–166
   PubMed Web of Science ®Google Scholar
• Krege S, Souchon R, Schmoll HJ. Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumours: Result of an update conference on evidence-based medicine (EBM). Eur Urol 2001; 40: 372–91
   PubMedGoogle Scholar